Please provide your email address to receive an email when new articles are posted on . The FDA has approved orphan drug designation for a new supplemental dialysate solution for patients on ...
Intratumoral Ral-binding protein 1 (RalBP1) expression as a potential predictor of bevacizumab treatment efficacy in patients with ovarian cancer. This is an ASCO Meeting Abstract from the 2024 ASCO ...
PATIENTS undergoing peritoneal dialysis frequently require antibiotic therapy for intraperitoneal and systemic infections. Since information concerning transperitoneal movement of antibiotics is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results